The Expert Speaker Faculty

Cath Lawrence

Head of Rare Disease

Bionical Emas

Dennis Akkaya

Chief Commercial Officer

myTomorrows

Isabelle Adeline

Chief of Staff & Director Special Projects, IP & Quality Assurance

MaaT Pharma

Laura Cox

Director of Partnerships

myTomorrows

Anne B. Cropp, Pharm.D.

Chief Scientific Officer

Early Access Care

Kirti Joshi

Global Operational Lead for Tepotinib Early Access

Merck Kgaa

Soetkin Vlassak

Senior Medical Director Global Medical Affairs Oncology

Merck Kgaa

Vilem Guryca

Global Program Lead & Managed Access

BeiGene

Carole Scrafton

Director & Co-Founder, Patient Advocate & Patient Speaker

Flutters and Strutters (FibroFlutters and ZebraStrutters)

Claire Wardell

Director, Managed Access Global Medical Affairs

GSK

Lindsay Weaver

Co-Founder

Realise Advocacy

Veronique Ollivier-Guillon

Global Program Leader Managed Access

Janssen

Ana Guersoni

Medical Affairs Brazil Lead

CSL Behring Biotherapies

Erin Lambet

Senior Director Expanded Access Program Lead

Argenx

François Houÿez

Treatment Information & Access Director & Health Policy Advisor

EURORDIS

Sara Radenovic

Associate Director, Managed Access

GSK

Magali Taiel

Chief Medical Officer

Gensight

Ramona Reichenbach

Head of Managed Access Centre of Excellence

Novartis

Shirle Zajac

Leader of Global Ethical Business, Shortages Response & Managed Access Programs

Teva

Sjaak Vink

Founder & CEO

Everyone.org

Anne Raimond-Thibaut

Global Oncology Data Generation Director, Global Medical & Patient Affairs

Servier

Karlijn Doorn PhD

Head of Operations

myTomorrows

Naomi Litchfield

Global Patient Advocacy Lead

Bionical Emas

Natasja van Roy

Global Program Leader, Director - Managed Access

Janssen